Form 4: Oscar Health CTO Sells Shares for Tax Obligations

Oscar Health's President of Technology & CTO, Mario Schlosser, disposed of 23,879 Class A common shares to cover tax withholding obligations related to RSU vesting.

Summary

• Mario Schlosser, Oscar Health's President of Technology & CTO, disposed of 23,879 shares of Class A Common Stock.
• The transaction occurred on September 2, 2025, at a price of $16.66 per share.
• These shares were withheld by Oscar Health to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs).
• Following this transaction, Schlosser beneficially owns 501,148 shares of Class A Common Stock, which includes shares to be issued from future RSU vesting.

Sentiment

Score: 6

Explanation: The transaction is a routine tax-related disposition following RSU vesting, which is a neutral event. The underlying RSU vesting is a positive for executive retention and compensation, slightly outweighing the minor reduction in direct shareholding.

Positives

• The underlying event, the vesting of restricted stock units (RSUs), indicates that performance or time-based conditions were met, which is generally a positive for executive compensation and retention.

Negatives

• The disposition of shares, even for tax purposes, reduces the direct equity stake of a key executive, though this is a common and expected practice.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a routine tax-related transaction. The underlying RSU vesting could be seen as a positive for executive alignment.
• Employees: No direct impact.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where an executive disposed of shares to cover tax obligations upon RSU vesting. Such transactions are common and generally do not indicate a change in the company's fundamental outlook or the executive's confidence. The underlying RSU vesting is a positive for executive retention. Therefore, this specific filing does not provide new information that would warrant a change in investment recommendation; a 'hold' stance remains appropriate based solely on this report.

Keywords

Oscar Health, OSCR, Mario Schlosser, Form 4, Insider Transaction, Stock Sale, RSU Vesting, Tax Withholding, Executive Compensation, Technology CTO